Literature DB >> 2847347

Bleeding symptoms in carriers of hemophilia A and B.

E P Mauser Bunschoten1, J C van Houwelingen, E J Sjamsoedin Visser, P J van Dijken, A J Kok, J J Sixma.   

Abstract

In order to investigate the bleeding tendency in clinically identified carriers of hemophilia, a self-administered questionnaire was held among 135 carriers of hemophilia A and B, 25 females with relatives with hemophilia and a matched group consisting of 60 females without relatives with hemophilia. Carriers of hemophilia appeared to suffer more often from bleeding than their relatives or the matched unrelated control group. A relation was seen between factor VIII:C or IX:C activity and the tendency to bleed. Obligatory carriers with normal factor VIII:C levels showed no bleeding tendency and were in this respect similar to a group of 25 females with relatives with hemophilia. This study shows that it is important to assay factor VIII:C or IX:C also in those women in whom the carrier status has already been established otherwise.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847347

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Bleeding symptoms in heterozygous factor XIII [corrected] deficiency.

Authors:  Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2010-09       Impact factor: 9.941

2.  Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes.

Authors:  L Gilbert; L Rollins; M Hilmes; Y Luo; D Gailani; M R Debaun; R F Sidonio
Journal:  Haemophilia       Date:  2014-09-23       Impact factor: 4.287

3.  Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

Authors:  A C Mauer; N A Khazanov; N Levenkova; S Tian; E M Barbour; C Khalida; J N Tobin; B S Coller
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

4.  Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding.

Authors:  Allison Paroskie; Olatunde Oso; Benjamin Almassi; Michael R DeBaun; Robert F Sidonio
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

5.  Females with FVIII and FIX deficiency have reduced joint range of motion.

Authors:  Robert F Sidonio; Fatima D Mili; Tengguo Li; Connie H Miller; William C Hooper; Michael R DeBaun; Michael Soucie
Journal:  Am J Hematol       Date:  2014-05-21       Impact factor: 10.047

Review 6.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

7.  Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues.

Authors:  Angela C Weyand; Robert F Sidonio; Michelle Sholzberg
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

8.  X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.

Authors:  Isabella Garagiola; Mimosa Mortarino; Simona Maria Siboni; Marco Boscarino; Maria Elisa Mancuso; Marina Biganzoli; Elena Santagostino; Flora Peyvandi
Journal:  Eur J Hum Genet       Date:  2020-10-20       Impact factor: 4.246

9.  The Role of Bleeding History and Clinical Markers for the Correct Diagnosis of VWD.

Authors:  Alberto Tosetto
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-12       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.